ORAL COMPOSITION FOR LIVER VLDL SYNTHESIS INHIBITION

摘要

PROBLEM TO BE SOLVED: To provide an oral composition for liver VLDL synthesis inhibition allowing less side effect even when taken and digested for a long term and having inhibitory action and the like against cholesterol ester synthesis, cholesterol synthesis, apolipoprotein B100 synthesis, apolipoprotein B100 secretion and microsome triglyceride-transferring protein synthesis in the liver.SOLUTION: An oral composition for liver VLDL synthesis inhibition is characterized by containing 2-(3,4-dihydroxyphenyl) ethanol.